ArticleBioengineering (Basel, Switzerland)2023
GNN-surv: Discrete-Time Survival Prediction Using Graph Neural Networks.
Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Survival prediction landscape: an in-depth systematic literature review on activities, methods, tools, diseases, and databases.Frontiers in artificial intelligence · 2024Pooled it
- Graph Neural Networks in Neuroimaging: Current Status and Biostatistical Considerations for Clinical Deployment.Annals of biomedical engineering · 2026Review
- Uncovering the Understanding of the Concept of Patient Similarity in Cancer Research and Treatment: Scoping Review.Journal of medical Internet research · 2025Article
- An efficient graph attention framework enhances bladder cancer prediction.Scientific reports · 2025Article
- Cox-Sage: enhancing Cox proportional hazards model with interpretable graph neural networks for cancer prognosis.Briefings in bioinformatics · 2025Article
- Radiomics-Based Machine Learning with Natural Gradient Boosting for Continuous Survival Prediction in Glioblastoma.Cancers · 2024Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Survival prediction models play a key role in patient prognosis and personalized treatment. However, their accuracy can be improved by incorporating patient similarity networks, which uncover complex data patterns. Our study uses Graph Neural Networks (GNNs) to enhance discrete-time survival predictions (GNN-surv) by leveraging relationships in these networks. We build these networks using cancer patients' genomic and clinical data and train various GNN models on them, integrating Logistic Hazard and PMF survival models. GNN-surv models exhibit superior performance in survival prediction across two urologic cancer datasets, outperforming traditional MLP models. They maintain robustness and effectiveness under varying graph construction hyperparameter μ values, with performance boosts of up to 14.6% and 7.9% in the time-dependent concordance index and reductions in the integrated brier score of 26.7% and 24.1% in the BLCA and KIRC datasets, respectively. Notably, these models also maintain their effectiveness across three different types of GNN models, suggesting potential adaptability to other cancer datasets. The superior performance of our GNN-surv models underscores their wide applicability in the fields of oncology and personalized medicine, providing clinicians with a more accurate tool for patient prognosis and personalized treatment planning. Future studies can further optimize these models by incorporating other survival models or additional data modalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.